Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
10 Jan 2022 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 January 2022 and 7 January 2022 Download
03 Jan 2022 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 27 December 2021 and 31 December 2021 Download
28 Dec 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 20 December 2021 and 24 December 2021 Download
20 Dec 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 13 December 2021 and 17 December 2021 Download
17 Dec 2021 On business and financial situation ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia Download

Pages

Date Title Description PDF
08 May 2019 Information on P&L ROVI releases the first quarter 2019 results presentation Download
08 May 2019 Information on P&L ROVI releases the press release related to the first quarter 2019 financial results Download
07 May 2019 Liquidity contracts and specialists ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A.     Download
30 Apr 2019 Liquidity contracts and specialists ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U.     Download
11 Apr 2019 Strategic agreements with third parties The Company releases the press release related to the marketing agreement of Tetridar® in Spain   Download

Pages